Milestone Pharmaceuticals (MIST)

• Market cap: $226M
• 1 day: -5.88%
• 5 days: -4%
• 1 month: 52.38%
• 3 months: -4.48%
• 6 months: -5.42%
• Year to date: -6.34%
• 1 year: 90.1%
• 5 years: -65.96%
• 10 years: -87.51%
• Sector: Healthcare
• Industry: Biotechnology

About: Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Employees: 38